Analyst Recommendations

Outperform Recommendation Issued On GTLB By RBC Capital
RBC Capital analyst issues OUTPERFORM recommendation for GTLB on March 5, 2024 02:36PM ET. The previous analyst recommendation was Outperform.GTLB was trading at $58.74 at issue of the...

March 5, 2024   GTLB 3.92%

Buy Recommendation Issued On GTLB By Canaccord Genuity
Canaccord Genuity analyst issues BUY recommendation for GTLB on March 5, 2024 02:36PM ET. The previous analyst recommendation was Buy.GTLB was trading at $58.74 at issue of the...

March 5, 2024   GTLB 3.92%

Underperform Recommendation Issued On ROE By Raymond James
Raymond James analyst issues UNDERPERFORM recommendation for ROE on March 5, 2024 01:01PM ET. The previous analyst recommendation was Underperform.ROE was trading at $0 at issue of the...

March 5, 2024   ROE 0.76%

Buy Recommendation Issued On SGRY By RBC Capital
RBC Capital analyst issues BUY recommendation for SGRY on March 5, 2024 01:01PM ET. The previous analyst recommendation was Buy.SGRY was trading at $30.63 at issue of the...

March 5, 2024   SGRY 0.18%

Sector Perform Recommendation Issued On PII By RBC Capital
RBC Capital analyst issues SECTOR PERFORM recommendation for PII on March 5, 2024 12:02PM ET. The previous analyst recommendation was Sector Perform.PII was trading at $93.62 at issue...

March 5, 2024   PII 1.81%

Outperform Recommendation Issued On BUD By Cowen & Co.
Cowen & Co. analyst issues OUTPERFORM recommendation for BUD on March 5, 2024 09:30AM ET. The previous analyst recommendation was Outperform.BUD was trading at $60.24 at issue of...

March 5, 2024   BUD 0.82%

Outperform Recommendation Issued On AAL By Bernstein
Bernstein analyst issues OUTPERFORM recommendation for AAL on March 5, 2024 09:30AM ET. The previous analyst recommendation was Outperform.AAL was trading at $14.62 at issue of the analyst...

March 5, 2024   AAL 0.95%

Buy Recommendation Issued On RNA By Chardan Capital
Chardan Capital analyst issues BUY recommendation for RNA on March 5, 2024 09:30AM ET. The previous analyst recommendation was Buy.RNA was trading at $19.48 at issue of the...

March 5, 2024   RNA -0.30%

Market Perform Recommendation Issued On FND By Wells Fargo
Wells Fargo analyst issues MARKET PERFORM recommendation for FND on March 5, 2024 11:00AM ET. The previous analyst recommendation was Market Perform.FND was trading at $120.75 at issue...

March 5, 2024   FND 0.07%

Outperform Recommendation Issued On REG By Evercore ISI
Evercore ISI analyst issues OUTPERFORM recommendation for REG on March 5, 2024 08:29AM ET. The previous analyst recommendation was Outperform.REG was trading at $62.7 at issue of the...

March 5, 2024   REG 0.60%